Supplementary Figure 4 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma

Authors:
  • NCNicole G. Chau
    Nicole G. Chau
  • YLYvonne Y. Li
    Yvonne Y. Li
  • VJVickie Y. Jo
    Vickie Y. Jo
  • GRGuilherme Rabinowits
    Guilherme Rabinowits
  • JLJochen H. Lorch
    Jochen H. Lorch
  • RTRoy B. Tishler
    Roy B. Tishler
  • DMDanielle N. Margalit
    Danielle N. Margalit
  • JSJonathan D. Schoenfeld
    Jonathan D. Schoenfeld
  • DADon J. Annino
    Don J. Annino
  • LGLaura A. Goguen
    Laura A. Goguen
  • TTTom Thomas
    Tom Thomas
  • HBHailey Becker
    Hailey Becker

Abstract
Presence of PIK3CA Amplification is Associated with Overall Survival Across the Oncopanel Cohort (n=109).